AVITA Medical, Inc., a regenerative medicine company, is expanding its presence in the United States, Australia, Japan, and the United Kingdom, offering innovative products to address unmet medical needs such as burn injuries, trauma injuries, chronic wounds, vitiligo, and dermatological and aesthetics indications. The company's patented platform technology provides treatment solutions that are derived from the regenerative properties of a patient's skin. Its lead product, RECELL System, is a platform technology that prepares and delivers spray-on skin cells for the treatment of acute thermal burns in patients 18 years and older, regenerating natural healthy epidermis. AVITA Medical, Inc. also has research agreements with the University of Colorado School of Medicine to establish pre-clinical proof-of-concept for a spray-on treatment of genetically corrected cells, and with Houston Methodist Research Institute to explore molecular reversal of cellular aging through a novel cell suspension delivery system. The company was formerly known as AVITA Therapeutics, Inc., and was incorporated in 2020, with headquarters in Valencia, California.
AVITA Medical's ticker is RCEL
The company's shares trade on the NASDAQ stock exchange
They are based in Santa Clarita, California
There are 51-200 employees working at AVITA Medical
It is avitamedical.com
AVITA Medical is in the Healthcare sector
AVITA Medical is in the Medical Appliances & Equipment industry
The following five companies are AVITA Medical's industry peers: